Brief: Everest Medicines Says Honorary Chairman Purchases 860,000 Shares For HK$32.7 Million On March 27
30/03/2026 05:19
March 30 (Reuters) - Everest Medicines Ltd 1952.HK: HONORARY CHAIRMAN PURCHASES 860,000 SHARES FOR HK$32.7 MILLION AT HK$38.12 PER SHARE ON MARCH 27 Further company coverage: 1952.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Everest Medicines
See all newsBrief: Everest Medicines Says NMPA Approves Cardamyst (Etripamil) NDA For PSVT In Adults In China
Brief: Everest Medicines Enters Commercialization Collaboration With Hainan Herui Pharmaceutical
Brief: Everest Medicines Says CBC Group Purchases 712,000 Everest Medicines Shares For Hk$19.2 Million From 16 To 17 June
Australia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region